About
Treatment for ion-related diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
74
By Phase
PHASE1: 2
By Status
TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05238207Lead Sponsor
A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers
PHASE1Terminated
24 participants
Started: Mar 28, 2022 · Completed: May 4, 2023
NCT04787003Collaborator
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
PHASE1Unknown
50 participants
Started: Feb 16, 2021 · Completed: Feb 28, 2024
Locations (1)
Headquarters
Parkville, MO, United States
Map
Loading map...